Global Perfusion Systems Market – Industry Analysis and Forecast (2018-2026) –By Component, Type, Product Type, Technique, Organ Type, and Region.

Global Perfusion Systems Market – Industry Analysis and Forecast (2018-2026) –By Component, Type, Product Type, Technique, Organ Type, and Region.

Market Scenario

Global perfusion systems market was valued US$ 940 Mn in 2017 and is expected to reach US$ 1311 Mn by 2026, at a CAGR of 4.25 % during a forecast period. Perfusion system is the medical term used for the passing of fluid into the circulatory system, an organ as well as body tissue. Perfusion systems are also used to temporarily exchange the functions of the heart & lungs during cardiac and thoracic surgery procedures. Global Perfusion Systems Market Growing occurrence of cardiovascular & respiratory diseases, an increasing number of organ transplantations, growth in aging population, and rising incidence of multiple organ failures are boosting the market growth. Government & NGO initiatives to inspire organ donation, growing funds in cell-based research, and rise in biologic manufacturing are also propelling the growth of global perfusion systems market. Organ supply-demand gap is the major challenge of the market. Rising pharmaceutical research in developing markets and increasing preference for continuous manufacturing are key opportunities of the global perfusion systems market. However, the high cost of organ transplantation, and ethical concerns & high cost of cell-based research are limiting the market growth. The cardiopulmonary perfusion systems segment is estimated for the largest share of the global perfusion systems market owing to the growing occurrence of cardiovascular & respiratory diseases and the rising number of organ transplant procedures. The oxygenators segment is projected to account for the largest share of the global cardiopulmonary perfusion systems market owing to the increasing incidence of cardiopulmonary failure. The hypothermic machine perfusion segment is expected to the largest share of the market owing to the high growth in this segment and the advantages offered by hypothermic machine perfusion, such as better long-term graft survival rates, reduced vasospasm, and capability to provide metabolic support. North America is leading the market followed by Europe, the Asia Pacific owing to the high occurrence of key players and growing collaborations among them to expand their products. Europe is estimated to witness significant growth in the global perfusion system market owing to growing agreements of new perfusion systems in the Europe region. The key players operating in the global perfusion systems market are ALA Scientific Instruments, Inc., Getinge AB, Harvard Bioscience, Inc., Lifeline Scientific, Inc. (Organ Recovery Systems, Inc.), Livanova PLC, Medtronic PLC, Merck KGaA, Nipro Corporation, Repligen Corporation, Spectrum Laboratories, Inc., Terumo Corporation, Xenios AG (Acquired By Fresenius Medical Care AG & Co. KGaA), and Xvivo Perfusion AB. The report covers a comprehensive study of major market drivers, restrains, opportunities, challenges, PESTEL, Porters, SWOT, and technological forecasting in the market.

The Scope of Global Perfusion Systems Market:

Global Perfusion Systems Market, by Component :

• Oxygenators • Heart-Lung Machines • Perfusion Pumps • Cannulas • Monitoring Systems • Other Components

Global Perfusion Systems Market, by Type:

• Bioreactor Perfusion Systems • Microfluidic Perfusion Systems • Gravity Or Pressure-Driven Perfusion Systems • Small-Mammal Organ Perfusion Systems

Global Perfusion Systems Market, by Product Type:

• Cardiopulmonary Perfusion Systems • Ex Vivo Organ Perfusion Systems • Cell Perfusion Systems

Global Perfusion Systems Market by Technique:

• Hypothermic • Normothermic

Global Perfusion Systems Market by Organ Type:

• Kidney • Heart • Lungs • Liver • Others

Global Perfusion Systems Market, by Region:

• North America • Europe • Middle East & Africa • Asia Pacific • Latin America

The Key Players Operating In the Global Perfusion Systems Market:

• ALA Scientific Instruments, Inc. • Getinge AB • Harvard Bioscience, Inc. • Lifeline Scientific, Inc. (Organ Recovery Systems, Inc.) • Livanova PLC • Medtronic PLC • Merck KGaA • Nipro Corporation • Repligen Corporation • Spectrum Laboratories, Inc. • Terumo Corporation • Xenios AG (Acquired By Fresenius Medical Care AG & Co. KGaA) • Xvivo Perfusion AB Global Blood Group Typing Market

Table of Contents

Global Perfusion Systems Market

1. Preface 1.1. Research Objectives 1.2. Report Scope and Market Segmentation 2. Assumptions and Research Methodology 2.1. Abbreviations 3. Executive Summary 3.1. Global Perfusion Systems Market Size, by Market Value (US$ Mn) and Market 4. Market Overview 4.1. Introduction 4.2. Market Dynamics 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 4.3.7. Key Trends in Global Perfusion Systems Market 5. Global Perfusion Systems Market Analysis and Forecast 5.1. Global Perfusion Systems Market Size & Y-o-Y Growth Analysis 5.1.1. North America 5.1.2. Europe 5.1.3. Asia Pacific 5.1.4. Middle East & Africa 5.1.5. South America 6. Global Perfusion Systems Market Analysis and Forecast, by Component 6.1. Introduction and Definition 6.2. Global Perfusion Systems Market Value Share Analysis, by Component 6.3. Global Perfusion Systems Market Size (US$ Mn) Forecast, by Component 6.4. Global Perfusion Systems Market Analysis, by Component 6.5. Global Perfusion Systems Market Attractiveness Analysis, by Component 6.6. Key Trends 6.6.1. Key Developments 7. Global Perfusion Systems Market Analysis and Forecast, by Type 7.1. Introduction and Definition 7.2. Global Perfusion Systems Market Value Share Analysis, by Type 7.3. Global Perfusion Systems Market Size (US$ Mn) Forecast, by Type 7.4. Global Perfusion Systems Market Analysis, by Type 7.5. Global Perfusion Systems Market Attractiveness Analysis, by Type 7.6. Key Trends 7.6.1. Key Developments 8. Global Perfusion Systems Market Analysis and Forecast, by Product Type 8.1. Introduction and Definition 8.2. Global Perfusion Systems Market Value Share Analysis, by Product Type 8.3. Global Perfusion Systems Market Size (US$ Mn) Forecast, by Product Type 8.4. Global Perfusion Systems Market Analysis, by Product Type 8.5. Global Perfusion Systems Market Attractiveness Analysis, by Product Type 9. Global Perfusion Systems Market Analysis and Forecast, by Techniques 9.1. Introduction and Definition 9.2. Global Perfusion Systems Market Value Share Analysis, by Techniques 9.3. Global Perfusion Systems Market Size (US$ Mn) Forecast, by Techniques 9.4. Global Perfusion Systems Market Analysis, by Techniques 9.5. Global Perfusion Systems Market Attractiveness Analysis, by Techniques 9.6. Key Trends 9.6.1. Key Developments 10. Global Perfusion Systems Market Analysis and Forecast, by Organ Type 10.1. Introduction and Definition 10.2. Global Perfusion Systems Market Value Share Analysis, by Organ Type 10.3. Global Perfusion Systems Market Size (US$ Mn) Forecast, by Organ Type 10.4. Global Perfusion Systems Market Analysis, by Organ Type 10.5. Global Perfusion Systems Market Attractiveness Analysis, by Organ Type 10.6. Key Trends 10.6.1. Key Developments 11. Global Perfusion Systems Market Analysis, by Region 11.1. Global Perfusion Systems Market Value Share Analysis, by Region 11.2. Global Perfusion Systems Market Size (US$ Mn) Forecast, by Region 11.3. Global Perfusion Systems Market Attractiveness Analysis, by Region 11.4. Key Trends 11.4.1. Key Developments 12. North America Perfusion Systems Market Analysis 12.1. North America Perfusion Systems Market Overview 12.2. North America Perfusion Systems Market Value Share Analysis, by Component 12.3. North America Perfusion Systems Market Forecast, by Component 12.3.1. Oxygenators 12.3.2. Heart-Lung Machines 12.3.3. Perfusion Pumps 12.3.4. Cannulas 12.3.5. Monitoring Systems 12.3.6. Other Components 12.4. North America Perfusion Systems Market Value Share Analysis, by Type 12.5. North America Perfusion Systems Market Forecast, by Type 12.5.1. Bioreactor Perfusion Systems 12.5.2. Microfluidic Perfusion Systems 12.5.3. Gravity Or Pressure-Driven Perfusion Systems 12.5.4. Small-Mammal Organ Perfusion Systems 12.6. North America Perfusion Systems Market Value Share Analysis, by Product Type 12.7. North America Perfusion Systems Market Forecast, by Product Type 12.7.1. Cardiopulmonary Perfusion Systems 12.7.2. Ex Vivo Organ Perfusion Systems 12.7.3. Cell Perfusion Systems 12.8. North America Perfusion Systems Market Value Share Analysis, by Techniques 12.9. North America Perfusion Systems Market Forecast, by Techniques 12.9.1. Hypothermic 12.9.2. Normothermic 12.10. North America Perfusion Systems Market Value Share Analysis, by Organ Type 12.11. North America Perfusion Systems Market Forecast, by Organ Type 12.11.1. Kidney 12.11.2. Heart 12.11.3. Lungs 12.11.4. Liver 12.11.5. Others 12.12. North America Perfusion Systems Market Value Share Analysis, by Country 12.13. North America Perfusion Systems Market Forecast, by Country 12.13.1. U.S. 12.13.2. Canada 12.14. North America Perfusion Systems Market Analysis, by Country 12.15. U.S. Perfusion Systems Market Forecast, by Component 12.15.1. Oxygenators 12.15.2. Heart-Lung Machines 12.15.3. Perfusion Pumps 12.15.4. Cannulas 12.15.5. Monitoring Systems 12.15.6. Other Components 12.16. U.S. Perfusion Systems Market Forecast, by Type 12.16.1. Bioreactor Perfusion Systems 12.16.2. Microfluidic Perfusion Systems 12.16.3. Gravity Or Pressure-Driven Perfusion Systems 12.16.4. Small-Mammal Organ Perfusion Systems 12.17. U.S. Perfusion Systems Market Forecast, by Product Type 12.17.1. Cardiopulmonary Perfusion Systems 12.17.2. Ex Vivo Organ Perfusion Systems 12.17.3. Cell Perfusion Systems 12.18. U.S. Perfusion Systems Market Forecast, by Techniques 12.18.1. Hypothermic 12.18.2. Normothermic 12.19. U.S. Perfusion Systems Market Forecast, by Organ Type 12.19.1. Kidney 12.19.2. Heart 12.19.3. Lungs 12.19.4. Liver 12.19.5. Others 12.20. Canada Perfusion Systems Market Forecast, by Component 12.20.1. Oxygenators 12.20.2. Heart-Lung Machines 12.20.3. Perfusion Pumps 12.20.4. Cannulas 12.20.5. Monitoring Systems 12.20.6. Other Components 12.21. Canada Perfusion Systems Market Forecast, by Type 12.21.1. Bioreactor Perfusion Systems 12.21.2. Microfluidic Perfusion Systems 12.21.3. Gravity Or Pressure-Driven Perfusion Systems 12.21.4. Small-Mammal Organ Perfusion Systems 12.22. Canada Perfusion Systems Market Forecast, by Product Type 12.22.1. Cardiopulmonary Perfusion Systems 12.22.2. Ex Vivo Organ Perfusion Systems 12.22.3. Cell Perfusion Systems 12.23. Canada Perfusion Systems Market Forecast, by Techniques 12.23.1. Hypothermic 12.23.2. Normothermic 12.24. Canada Perfusion Systems Market Forecast, by Organ Type 12.24.1. Kidney 12.24.2. Heart 12.24.3. Lungs 12.24.4. Liver 12.24.5. Others 12.25. North America Perfusion Systems Market Attractiveness Analysis 12.25.1. By Component 12.25.2. By Type 12.25.3. By Product Type 12.25.4. By Techniques 12.25.5. By Organ Type 12.26. PEST Analysis 12.27. Key Trends 12.27.1. Key Developments 13. Europe Perfusion Systems Market Analysis 13.1. Key Findings 13.2. Europe Perfusion Systems Market Overview 13.3. Europe Perfusion Systems Market Value Share Analysis, by Component 13.4. Europe Perfusion Systems Market Forecast, by Component 13.4.1. Oxygenators 13.4.2. Heart-Lung Machines 13.4.3. Perfusion Pumps 13.4.4. Cannulas 13.4.5. Monitoring Systems 13.4.6. Other Components 13.5. Europe Perfusion Systems Market Value Share Analysis, by Type 13.6. Europe Perfusion Systems Market Forecast, by Type 13.6.1. Bioreactor Perfusion Systems 13.6.2. Microfluidic Perfusion Systems 13.6.3. Gravity Or Pressure-Driven Perfusion Systems 13.6.4. Small-Mammal Organ Perfusion Systems 13.7. Europe Perfusion Systems Market Value Share Analysis, by Product Type 13.8. Europe Perfusion Systems Market Forecast, by Product Type 13.8.1. Cardiopulmonary Perfusion Systems 13.8.2. Ex Vivo Organ Perfusion Systems 13.8.3. Cell Perfusion Systems 13.9. Europe Perfusion Systems Market Value Share Analysis, by Techniques 13.10. Europe Perfusion Systems Market Forecast, by Techniques 13.10.1. Hypothermic 13.10.2. Normothermic 13.11. Europe Perfusion Systems Market Value Share Analysis, by Organ Type 13.12. Europe Perfusion Systems Market Forecast, by Organ Type 13.12.1. Kidney 13.12.2. Heart 13.12.3. Lungs 13.12.4. Liver 13.12.5. Others 13.13. Europe Perfusion Systems Market Value Share Analysis, by Country 13.14. Europe Perfusion Systems Market Forecast, by Country 13.14.1. Germany 13.14.2. U.K. 13.14.3. France 13.14.4. Italy 13.14.5. Spain 13.14.6. Rest of Europe 13.15. Europe Perfusion Systems Market Analysis, by Country/ Sub-region 13.16. Germany Perfusion Systems Market Forecast, by Component 13.16.1. Oxygenators 13.16.2. Heart-Lung Machines 13.16.3. Perfusion Pumps 13.16.4. Cannulas 13.16.5. Monitoring Systems 13.16.6. Other Components 13.17. Germany Perfusion Systems Market Forecast, by Type 13.17.1. Bioreactor Perfusion Systems 13.17.2. Microfluidic Perfusion Systems 13.17.3. Gravity Or Pressure-Driven Perfusion Systems 13.17.4. Small-Mammal Organ Perfusion Systems 13.18. Germany Perfusion Systems Market Forecast, by Product Type 13.18.1. Cardiopulmonary Perfusion Systems 13.18.2. Ex Vivo Organ Perfusion Systems 13.18.3. Cell Perfusion Systems 13.19. Germany Perfusion Systems Market Forecast, by Techniques 13.19.1. Hypothermic 13.19.2. Normothermic 13.20. Germany Perfusion Systems Market Forecast, by Organ Type 13.20.1. Kidney 13.20.2. Heart 13.20.3. Lungs 13.20.4. Liver 13.20.5. Others 13.21. U.K. Perfusion Systems Market Forecast, by Component 13.21.1. Oxygenators 13.21.2. Heart-Lung Machines 13.21.3. Perfusion Pumps 13.21.4. Cannulas 13.21.5. Monitoring Systems 13.21.6. Other Components 13.22. U.K. Perfusion Systems Market Forecast, by Type 13.22.1. Bioreactor Perfusion Systems 13.22.2. Microfluidic Perfusion Systems 13.22.3. Gravity Or Pressure-Driven Perfusion Systems 13.22.4. Small-Mammal Organ Perfusion Systems 13.23. U.K. Perfusion Systems Market Forecast, by Product Type 13.23.1. Cardiopulmonary Perfusion Systems 13.23.2. Ex Vivo Organ Perfusion Systems 13.23.3. Cell Perfusion Systems 13.24. U.K. Perfusion Systems Market Forecast, by Techniques 13.24.1. Hypothermic 13.24.2. Normothermic 13.25. U.K. Perfusion Systems Market Forecast, by Organ Type 13.25.1. Kidney 13.25.2. Heart 13.25.3. Lungs 13.25.4. Liver 13.25.5. Others 13.26. France Perfusion Systems Market Forecast, by Component 13.26.1. Oxygenators 13.26.2. Heart-Lung Machines 13.26.3. Perfusion Pumps 13.26.4. Cannulas 13.26.5. Monitoring Systems 13.26.6. Other Components 13.27. France Perfusion Systems Market Forecast, by Type 13.27.1. Bioreactor Perfusion Systems 13.27.2. Microfluidic Perfusion Systems 13.27.3. Gravity Or Pressure-Driven Perfusion Systems 13.27.4. Small-Mammal Organ Perfusion Systems 13.28. France Perfusion Systems Market Forecast, by Product Type 13.28.1. Cardiopulmonary Perfusion Systems 13.28.2. Ex Vivo Organ Perfusion Systems 13.28.3. Cell Perfusion Systems 13.29. France Perfusion Systems Market Forecast, by Techniques 13.29.1. Hypothermic 13.29.2. Normothermic 13.30. France Perfusion Systems Market Forecast, by Organ Type 13.30.1. Kidney 13.30.2. Heart 13.30.3. Lungs 13.30.4. Liver 13.30.5. Others 13.31. Italy Perfusion Systems Market Forecast, by Component 13.31.1. Oxygenators 13.31.2. Heart-Lung Machines 13.31.3. Perfusion Pumps 13.31.4. Cannulas 13.31.5. Monitoring Systems 13.31.6. Other Components 13.32. Italy Perfusion Systems Market Forecast, by Type 13.32.1. Bioreactor Perfusion Systems 13.32.2. Microfluidic Perfusion Systems 13.32.3. Gravity Or Pressure-Driven Perfusion Systems 13.32.4. Small-Mammal Organ Perfusion Systems 13.33. Italy Perfusion Systems Market Forecast, by Product Type 13.33.1. Cardiopulmonary Perfusion Systems 13.33.2. Ex Vivo Organ Perfusion Systems 13.33.3. Cell Perfusion Systems 13.34. Italy Perfusion Systems Market Forecast, by Techniques 13.34.1. Hypothermic 13.34.2. Normothermic 13.35. Italy Perfusion Systems Market Forecast, by Organ Type 13.35.1. Kidney 13.35.2. Heart 13.35.3. Lungs 13.35.4. Liver 13.35.5. Others 13.36. Spain Perfusion Systems Market Forecast, by Component 13.36.1. Oxygenators 13.36.2. Heart-Lung Machines 13.36.3. Perfusion Pumps 13.36.4. Cannulas 13.36.5. Monitoring Systems 13.36.6. Other Components 13.37. Spain Perfusion Systems Market Forecast, by Type 13.37.1. Bioreactor Perfusion Systems 13.37.2. Microfluidic Perfusion Systems 13.37.3. Gravity Or Pressure-Driven Perfusion Systems 13.37.4. Small-Mammal Organ Perfusion Systems 13.38. Spain Perfusion Systems Market Forecast, by Product Type 13.38.1. Cardiopulmonary Perfusion Systems 13.38.2. Ex Vivo Organ Perfusion Systems 13.38.3. Cell Perfusion Systems 13.39. Spain Perfusion Systems Market Forecast, by Techniques 13.39.1. Hypothermic 13.39.2. Normothermic 13.40. Spain Perfusion Systems Market Forecast, by Organ Type 13.40.1. Kidney 13.40.2. Heart 13.40.3. Lungs 13.40.4. Liver 13.40.5. Others 13.41. Rest of Europe Perfusion Systems Market Forecast, by Component 13.41.1. Oxygenators 13.41.2. Heart-Lung Machines 13.41.3. Perfusion Pumps 13.41.4. Cannulas 13.41.5. Monitoring Systems 13.41.6. Other Components 13.42. Rest of Europe Perfusion Systems Market Forecast, by Type 13.42.1. Bioreactor Perfusion Systems 13.42.2. Microfluidic Perfusion Systems 13.42.3. Gravity Or Pressure-Driven Perfusion Systems 13.42.4. Small-Mammal Organ Perfusion Systems 13.43. Rest of Europe Perfusion Systems Market Forecast, by Product Type 13.43.1. Cardiopulmonary Perfusion Systems 13.43.2. Ex Vivo Organ Perfusion Systems 13.43.3. Cell Perfusion Systems 13.44. Rest Of Europe Perfusion Systems Market Forecast, by Techniques 13.44.1. Hypothermic 13.44.2. Normothermic 13.45. Rest Of Europe Perfusion Systems Market Forecast, by Organ Type 13.45.1. Kidney 13.45.2. Heart 13.45.3. Lungs 13.45.4. Liver 13.45.5. Others 13.46. Europe Perfusion Systems Market Attractiveness Analysis 13.46.1. By Component 13.46.2. By Type 13.46.3. By Product Type 13.46.4. By Techniques 13.46.5. By Organ Type 13.47. PEST Analysis 13.48. Key Trends 13.48.1. Key Developments 14. Asia Pacific Perfusion Systems Market Analysis 14.1. Key Findings 14.2. Asia Pacific Perfusion Systems Market Overview 14.3. Asia Pacific Perfusion Systems Market Value Share Analysis, by Component 14.4. Asia Pacific Perfusion Systems Market Forecast, by Component 14.4.1. Oxygenators 14.4.2. Heart-Lung Machines 14.4.3. Perfusion Pumps 14.4.4. Cannulas 14.4.5. Monitoring Systems 14.4.6. Other Components 14.5. Asia Pacific Perfusion Systems Market Value Share Analysis, by Type 14.6. Asia Pacific Perfusion Systems Market Forecast, by Type 14.6.1. Bioreactor Perfusion Systems 14.6.2. Microfluidic Perfusion Systems 14.6.3. Gravity Or Pressure-Driven Perfusion Systems 14.6.4. Small-Mammal Organ Perfusion Systems 14.7. Asia Pacific Perfusion Systems Market Value Share Analysis, by Product Type 14.8. Asia Pacific Perfusion Systems Market Forecast, by Product Type 14.8.1. Cardiopulmonary Perfusion Systems 14.8.2. Ex Vivo Organ Perfusion Systems 14.8.3. Cell Perfusion Systems 14.9. Asia Pacific Perfusion Systems Market Value Share Analysis, by Techniques 14.10. Asia Pacific Perfusion Systems Market Forecast, by Techniques 14.10.1. Hypothermic 14.10.2. Normothermic 14.11. Asia Pacific Perfusion Systems Market Value Share Analysis, by Organ Type 14.12. Asia Pacific Perfusion Systems Market Forecast, by Organ Type 14.12.1. Kidney 14.12.2. Heart 14.12.3. Lungs 14.12.4. Liver 14.12.5. Others 14.13. Asia Pacific Perfusion Systems Market Value Share Analysis, by Country 14.14. Asia Pacific Perfusion Systems Market Forecast, by Country 14.14.1. China 14.14.2. India 14.14.3. Japan 14.14.4. ASEAN 14.14.5. Rest of Asia Pacific 14.15. Asia Pacific Perfusion Systems Market Analysis, by Country/ Sub-region 14.16. China Perfusion Systems Market Forecast, by Component 14.16.1. Oxygenators 14.16.2. Heart-Lung Machines 14.16.3. Perfusion Pumps 14.16.4. Cannulas 14.16.5. Monitoring Systems 14.16.6. Other Components 14.17. China Perfusion Systems Market Forecast, by Type 14.17.1. Bioreactor Perfusion Systems 14.17.2. Microfluidic Perfusion Systems 14.17.3. Gravity Or Pressure-Driven Perfusion Systems 14.17.4. Small-Mammal Organ Perfusion Systems 14.18. China Perfusion Systems Market Forecast, by Product Type 14.18.1. Cardiopulmonary Perfusion Systems 14.18.2. Ex Vivo Organ Perfusion Systems 14.18.3. Cell Perfusion Systems 14.19. China Perfusion Systems Market Forecast, by Techniques 14.19.1. Hypothermic 14.19.2. Normothermic 14.20. China Perfusion Systems Market Forecast, by Organ Type 14.20.1. Kidney 14.20.2. Heart 14.20.3. Lungs 14.20.4. Liver 14.20.5. Others 14.21. India Perfusion Systems Market Forecast, by Component 14.21.1. Oxygenators 14.21.2. Heart-Lung Machines 14.21.3. Perfusion Pumps 14.21.4. Cannulas 14.21.5. Monitoring Systems 14.21.6. Other Components 14.22. India Perfusion Systems Market Forecast, by Type 14.22.1. Bioreactor Perfusion Systems 14.22.2. Microfluidic Perfusion Systems 14.22.3. Gravity Or Pressure-Driven Perfusion Systems 14.22.4. Small-Mammal Organ Perfusion Systems 14.23. India Perfusion Systems Market Forecast, by Product Type 14.23.1. Cardiopulmonary Perfusion Systems 14.23.2. Ex Vivo Organ Perfusion Systems 14.23.3. Cell Perfusion Systems 14.24. India Perfusion Systems Market Forecast, by Techniques 14.24.1. Hypothermic 14.24.2. Normothermic 14.25. India Perfusion Systems Market Forecast, by Organ Type 14.25.1. Kidney 14.25.2. Heart 14.25.3. Lungs 14.25.4. Liver 14.25.5. Others 14.26. Japan Perfusion Systems Market Forecast, by Component 14.26.1. Oxygenators 14.26.2. Heart-Lung Machines 14.26.3. Perfusion Pumps 14.26.4. Cannulas 14.26.5. Monitoring Systems 14.26.6. Other Components 14.27. Japan Perfusion Systems Market Forecast, by Type 14.27.1. Bioreactor Perfusion Systems 14.27.2. Microfluidic Perfusion Systems 14.27.3. Gravity Or Pressure-Driven Perfusion Systems 14.27.4. Small-Mammal Organ Perfusion Systems 14.28. Japan Perfusion Systems Market Forecast, by Product Type 14.28.1. Cardiopulmonary Perfusion Systems 14.28.2. Ex Vivo Organ Perfusion Systems 14.28.3. Cell Perfusion Systems 14.29. Japan Perfusion Systems Market Forecast, by Techniques 14.29.1. Hypothermic 14.29.2. Normothermic 14.30. Japan Perfusion Systems Market Forecast, by Organ Type 14.30.1. Kidney 14.30.2. Heart 14.30.3. Lungs 14.30.4. Liver 14.30.5. Others 14.31. ASEAN Perfusion Systems Market Forecast, by Component 14.31.1. Oxygenators 14.31.2. Heart-Lung Machines 14.31.3. Perfusion Pumps 14.31.4. Cannulas 14.31.5. Monitoring Systems 14.31.6. Other Components 14.32. ASEAN Perfusion Systems Market Forecast, by Type 14.32.1. Bioreactor Perfusion Systems 14.32.2. Microfluidic Perfusion Systems 14.32.3. Gravity Or Pressure-Driven Perfusion Systems 14.32.4. Small-Mammal Organ Perfusion Systems 14.33. ASEAN Perfusion Systems Market Forecast, by Product Type 14.33.1. Cardiopulmonary Perfusion Systems 14.33.2. Ex Vivo Organ Perfusion Systems 14.33.3. Cell Perfusion Systems 14.34. ASEAN Perfusion Systems Market Forecast, by Techniques 14.34.1. Hypothermic 14.34.2. Normothermic 14.35. ASEAN Perfusion Systems Market Forecast, by Organ Type 14.35.1. Kidney 14.35.2. Heart 14.35.3. Lungs 14.35.4. Liver 14.35.5. Others 14.36. Rest of Asia Pacific Perfusion Systems Market Forecast, by Component 14.36.1. Oxygenators 14.36.2. Heart-Lung Machines 14.36.3. Perfusion Pumps 14.36.4. Cannulas 14.36.5. Monitoring Systems 14.36.6. Other Components 14.37. Rest of Asia Pacific Perfusion Systems Market Forecast, by Type 14.37.1. Bioreactor Perfusion Systems 14.37.2. Microfluidic Perfusion Systems 14.37.3. Gravity Or Pressure-Driven Perfusion Systems 14.37.4. Small-Mammal Organ Perfusion Systems 14.38. Rest of Asia Pacific Perfusion Systems Market Forecast, by Product Type 14.38.1. Cardiopulmonary Perfusion Systems 14.38.2. Ex Vivo Organ Perfusion Systems 14.38.3. Cell Perfusion Systems 14.39. Rest of Asia Pacific Perfusion Systems Market Forecast, by Techniques 14.39.1. Hypothermic 14.39.2. Normothermic 14.40. Rest of Asia Pacific Perfusion Systems Market Forecast, by Organ Type 14.40.1. Kidney 14.40.2. Heart 14.40.3. Lungs 14.40.4. Liver 14.40.5. Others 14.41. Asia Pacific Perfusion Systems Market Attractiveness Analysis 14.41.1. By Component 14.41.2. By Type 14.41.3. By Product Type 14.41.4. By Techniques 14.41.5. By Organ Type 14.42. PEST Analysis 14.43. Key Trends 14.43.1. Key Developments 15. Middle East & Africa Perfusion Systems Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Perfusion Systems Market Overview 15.3. Middle East & Africa Perfusion Systems Market Value Share Analysis, by Component 15.4. Middle East & Africa Perfusion Systems Market Forecast, by Component 15.4.1. Oxygenators 15.4.2. Heart-Lung Machines 15.4.3. Perfusion Pumps 15.4.4. Cannulas 15.4.5. Monitoring Systems 15.4.6. Other Components 15.5. Middle East & Africa Perfusion Systems Market Value Share Analysis, by Type 15.6. Middle East & Africa Perfusion Systems Market Forecast, by Type 15.6.1. Bioreactor Perfusion Systems 15.6.2. Microfluidic Perfusion Systems 15.6.3. Gravity Or Pressure-Driven Perfusion Systems 15.6.4. Small-Mammal Organ Perfusion Systems 15.7. Middle East & Africa Perfusion Systems Market Value Share Analysis, by Product Type 15.8. Middle East & Africa Perfusion Systems Market Forecast, by Product Type 15.8.1. Cardiopulmonary Perfusion Systems 15.8.2. Ex Vivo Organ Perfusion Systems 15.8.3. Cell Perfusion Systems 15.9. Middle East & Africa Perfusion Systems Market Value Share Analysis, by Techniques 15.10. Middle East & Africa Perfusion Systems Market Forecast, by Techniques 15.10.1. Hypothermic 15.10.2. Normothermic 15.11. Middle East & Africa Perfusion Systems Market Value Share Analysis, by Organ Type 15.12. Middle East & Africa Perfusion Systems Market Forecast, by Organ Type 15.12.1. Kidney 15.12.2. Heart 15.12.3. Lungs 15.12.4. Liver 15.12.5. Others 15.13. Middle East & Africa Perfusion Systems Market Value Share Analysis, by Country 15.14. Middle East & Africa Perfusion Systems Market Forecast, by Country 15.14.1. GCC 15.14.2. South Africa 15.14.3. Rest of Middle East & Africa 15.15. Middle East & Africa Perfusion Systems Market Analysis, by Country/ Sub-region 15.16. GCC Perfusion Systems Market Forecast, by Component 15.16.1. Oxygenators 15.16.2. Heart-Lung Machines 15.16.3. Perfusion Pumps 15.16.4. Cannulas 15.16.5. Monitoring Systems 15.16.6. Other Components 15.17. GCC Perfusion Systems Market Forecast, by Type 15.17.1. Bioreactor Perfusion Systems 15.17.2. Microfluidic Perfusion Systems 15.17.3. Gravity Or Pressure-Driven Perfusion Systems 15.17.4. Small-Mammal Organ Perfusion Systems 15.18. GCC Perfusion Systems Market Forecast, by Product Type 15.18.1. Cardiopulmonary Perfusion Systems 15.18.2. Ex Vivo Organ Perfusion Systems 15.18.3. Cell Perfusion Systems 15.19. GCC Perfusion Systems Market Forecast, by Techniques 15.19.1. Hypothermic 15.19.2. Normothermic 15.20. GCC Perfusion Systems Market Forecast, by Organ Type 15.20.1. Kidney 15.20.2. Heart 15.20.3. Lungs 15.20.4. Liver 15.20.5. Others 15.21. South Africa Perfusion Systems Market Forecast, by Component 15.21.1. Oxygenators 15.21.2. Heart-Lung Machines 15.21.3. Perfusion Pumps 15.21.4. Cannulas 15.21.5. Monitoring Systems 15.21.6. Other Components 15.22. South Africa Perfusion Systems Market Forecast, by Type 15.22.1. Bioreactor Perfusion Systems 15.22.2. Microfluidic Perfusion Systems 15.22.3. Gravity Or Pressure-Driven Perfusion Systems 15.22.4. Small-Mammal Organ Perfusion Systems 15.23. South Africa Perfusion Systems Market Forecast, by Product Type 15.23.1. Cardiopulmonary Perfusion Systems 15.23.2. Ex Vivo Organ Perfusion Systems 15.23.3. Cell Perfusion Systems 15.24. South Africa Perfusion Systems Market Forecast, by Techniques 15.24.1. Hypothermic 15.24.2. Normothermic 15.25. South Africa Perfusion Systems Market Forecast, by Organ Type 15.25.1. Kidney 15.25.2. Heart 15.25.3. Lungs 15.25.4. Liver 15.25.5. Others 15.26. Rest of Middle East & Africa Perfusion Systems Market Forecast, by Component 15.26.1. Oxygenators 15.26.2. Heart-Lung Machines 15.26.3. Perfusion Pumps 15.26.4. Cannulas 15.26.5. Monitoring Systems 15.26.6. Other Components 15.27. Rest of Middle East & Africa Perfusion Systems Market Forecast, by Type 15.27.1. Bioreactor Perfusion Systems 15.27.2. Microfluidic Perfusion Systems 15.27.3. Gravity Or Pressure-Driven Perfusion Systems 15.27.4. Small-Mammal Organ Perfusion Systems 15.28. Rest of Middle East & Africa Perfusion Systems Market Forecast, by Product Type 15.28.1. Cardiopulmonary Perfusion Systems 15.28.2. Ex Vivo Organ Perfusion Systems 15.28.3. Cell Perfusion Systems 15.29. Rest of Middle East & Africa Perfusion Systems Market Forecast, by Techniques 15.29.1. Hypothermic 15.29.2. Normothermic 15.30. Rest of Middle East & Africa Perfusion Systems Market Forecast, by Organ Type 15.30.1. Kidney 15.30.2. Heart 15.30.3. Lungs 15.30.4. Liver 15.30.5. Others 15.31. Middle East & Africa Perfusion Systems Market Attractiveness Analysis 15.31.1. By Component 15.31.2. By Type 15.31.3. By Product Type 15.31.4. By Techniques 15.31.5. By Organ Type 15.32. PEST Analysis 15.33. Key Trends 15.33.1. Key Developments 16. South America Perfusion Systems Market Analysis 16.1. Key Findings 16.2. South America Perfusion Systems Market Overview 16.3. South America Perfusion Systems Market Value Share Analysis, by Component 16.4. South America Perfusion Systems Market Forecast, by Component 16.4.1. Oxygenators 16.4.2. Heart-Lung Machines 16.4.3. Perfusion Pumps 16.4.4. Cannulas 16.4.5. Monitoring Systems 16.4.6. Other Components 16.5. South America Perfusion Systems Market Value Share Analysis, by Type 16.6. South America Perfusion Systems Market Forecast, by Type 16.6.1. Bioreactor Perfusion Systems 16.6.2. Microfluidic Perfusion Systems 16.6.3. Gravity Or Pressure-Driven Perfusion Systems 16.6.4. Small-Mammal Organ Perfusion Systems 16.7. South America Perfusion Systems Market Value Share Analysis, by Product Type 16.8. South America Perfusion Systems Market Forecast, by Product Type 16.8.1. Cardiopulmonary Perfusion Systems 16.8.2. Ex Vivo Organ Perfusion Systems 16.8.3. Cell Perfusion Systems 16.9. South America Perfusion Systems Market Value Share Analysis, by Techniques 16.10. South America Perfusion Systems Market Forecast, by Techniques 16.10.1. Hypothermic 16.10.2. Normothermic 16.11. South America Perfusion Systems Market Value Share Analysis, by Organ Type 16.12. South America Perfusion Systems Market Forecast, by Organ Type 16.12.1. Kidney 16.12.2. Heart 16.12.3. Lungs 16.12.4. Liver 16.12.5. Others 16.13. South America Perfusion Systems Market Value Share Analysis, by Country 16.14. South America Perfusion Systems Market Forecast, by Country 16.14.1. Brazil 16.14.2. Mexico 16.14.3. Rest of South America 16.15. South America Perfusion Systems Market Analysis, by Country/ Sub-region 16.16. Brazil Perfusion Systems Market Forecast, by Component 16.16.1. Oxygenators 16.16.2. Heart-Lung Machines 16.16.3. Perfusion Pumps 16.16.4. Cannulas 16.16.5. Monitoring Systems 16.16.6. Other Components 16.17. Brazil Perfusion Systems Market Forecast, by Type 16.17.1. Bioreactor Perfusion Systems 16.17.2. Microfluidic Perfusion Systems 16.17.3. Gravity Or Pressure-Driven Perfusion Systems 16.17.4. Small-Mammal Organ Perfusion Systems 16.18. Brazil Perfusion Systems Market Forecast, by Product Type 16.18.1. Cardiopulmonary Perfusion Systems 16.18.2. Ex Vivo Organ Perfusion Systems 16.18.3. Cell Perfusion Systems 16.19. Brazil Perfusion Systems Market Forecast, by Techniques 16.19.1. Hypothermic 16.19.2. Normothermic 16.20. Brazil Perfusion Systems Market Forecast, by Organ Type 16.20.1. Kidney 16.20.2. Heart 16.20.3. Lungs 16.20.4. Liver 16.20.5. Others 16.21. Mexico Perfusion Systems Market Forecast, by Component 16.21.1. Oxygenators 16.21.2. Heart-Lung Machines 16.21.3. Perfusion Pumps 16.21.4. Cannulas 16.21.5. Monitoring Systems 16.21.6. Other Components 16.22. Mexico Perfusion Systems Market Forecast, by Type 16.22.1. Bioreactor Perfusion Systems 16.22.2. Microfluidic Perfusion Systems 16.22.3. Gravity Or Pressure-Driven Perfusion Systems 16.22.4. Small-Mammal Organ Perfusion Systems 16.23. Mexico Perfusion Systems Market Forecast, by Product Type 16.23.1. Cardiopulmonary Perfusion Systems 16.23.2. Ex Vivo Organ Perfusion Systems 16.23.3. Cell Perfusion Systems 16.24. Mexico Perfusion Systems Market Forecast, by Techniques 16.24.1. Hypothermic 16.24.2. Normothermic 16.25. Mexico Perfusion Systems Market Forecast, by Organ Type 16.25.1. Kidney 16.25.2. Heart 16.25.3. Lungs 16.25.4. Liver 16.25.5. Others 16.26. Rest of South America Perfusion Systems Market Forecast, by Component 16.26.1. Oxygenators 16.26.2. Heart-Lung Machines 16.26.3. Perfusion Pumps 16.26.4. Cannulas 16.26.5. Monitoring Systems 16.26.6. Other Components 16.27. Rest of South America Perfusion Systems Market Forecast, by Type 16.27.1. Bioreactor Perfusion Systems 16.27.2. Microfluidic Perfusion Systems 16.27.3. Gravity Or Pressure-Driven Perfusion Systems 16.27.4. Small-Mammal Organ Perfusion Systems 16.28. Rest of South America Perfusion Systems Market Forecast, by Product Type 16.28.1. Cardiopulmonary Perfusion Systems 16.28.2. Ex Vivo Organ Perfusion Systems 16.28.3. Cell Perfusion Systems 16.29. Rest of South America Perfusion Systems Market Forecast, by Techniques 16.29.1. Hypothermic 16.29.2. Normothermic 16.30. Rest of South America Perfusion Systems Market Forecast, by Organ Type 16.30.1. Kidney 16.30.2. Heart 16.30.3. Lungs 16.30.4. Liver 16.30.5. Others 16.31. South America Perfusion Systems Market Attractiveness Analysis 16.31.1. By Component 16.31.2. By Type 16.31.3. By Product Type 16.31.4. By Techniques 16.31.5. By Organ Type 16.32. PEST Analysis 16.33. Key Trends 16.33.1. Key Developments 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.3. Company Profiles: Key Players 17.4. Competitive Benchmarking of Company and Rheolytic Thrombectomy Devices 17.5. Company Profiles: Key Players 17.5.1. Xvivo Perfusion AB 17.5.1.1. Company Overview 17.5.1.2. Financial Overview 17.5.1.3. Business Strategy 17.5.1.4. Recent Developments 17.5.1.5. Development Footprint 17.5.2. ALA Scientific Instruments, Inc. 17.5.3. Getinge AB 17.5.4. Harvard Bioscience, Inc. 17.5.5. Lifeline Scientific, Inc. (Organ Recovery Systems, Inc.) 17.5.6. Livanova PLC 17.5.7. Medtronic PLC 17.5.8. Merck KGaA 17.5.9. Nipro Corporation 17.5.10. Repligen Corporation 17.5.11. Spectrum Laboratories, Inc. 17.5.12. Terumo Corporation 17.5.13. Xenios AG (Acquired By Fresenius Medical Care AG & Co. KGaA) 18. Primary Key Insights

About This Report

Report ID22598
Published DateJan 2019
Contact Us
Call Now